Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age-Reference-Cited by-同舟云学术

Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age

Published:2022-03-03 Issue:3 Volume:39 Page:389-393
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatric Dermatology

Author:

Gatts Jorie E.¹,Rush Marie C.²,Check Jennifer F.¹,Samelak Diane M.¹,McLean Thomas W.¹^ORCID

Affiliation:

1. Department of Pediatrics Wake Forest School of Medicine Winston‐Salem North Carolina USA

2. Department of Pharmacy Wake Forest Baptist Health Winston‐Salem North Carolina USA

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.14966

Reference24 articles.

1. Clinical Practice Guideline for the Management of Infantile Hemangiomas

2. Hemangeol (propranolol hydrochloride) oral solution. U.S. Food and Drug Administration. Drug Approvals and Databases.https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205410Orig1s000TOC.cfm. Accessed February 7 2022.

3. Early Growth of Infantile Hemangiomas: What Parents’ Photographs Tell Us

4. Diagnosis and Management of Infantile Hemangioma

5. A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propranolol;Reactions Weekly;2024-06-22

2. Practice Variations in Managing Infantile Hemangiomas;Journal of Pediatric Hematology/Oncology;2023-09-26

3. Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospital;European Journal of Dermatology;2023-06

4. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population;Scientific Reports;2023-04-12

5. Side effects of β-adrenergic antagonists and antianginal drugs;Side Effects of Drugs Annual;2023